MedTrace Logo

Pneumacare SLP Validation in Infants and in Clinical Bronchiolitis

NCT02881632 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-08-29

No results posted yet for this study

Summary

A cohort observational study to characterise baseline Structured Light Plethysmography (SLP) outputs in infants with bronchiolitis and examine response to treatment using the Thora3DiTM

Conditions

  • Bronchiolitis

Interventions

DEVICE

Structured Light Plethysmography (SLP) - Pneumscan

Both healthy infants and bronchiolitis infants will have their chest movements monitored using Structured Light Plethysmography (SLP) performed by a device (Thora-3 Di) using a projector and two cameras. A light pattern of black and white squares is projected on the child's chest and the cameras record how the shape of this pattern changes with breathing. A computer converts this information to show how the child's chest moves during breathing.

Sponsors & Collaborators

  • Pneumacare Ltd

    collaborator INDUSTRY

  • University Hospitals of North Midlands NHS Trust

    lead OTHER

Principal Investigators

  • John Alexander · UHNM

Eligibility

Min Age
1 Minute
Max Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02881632 on ClinicalTrials.gov